Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-08

Clinical Trial Update: AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of AMG 531 in patients with advanced solid tumors receiving carboplatin completed; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMG 531 (AMG531)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Solid Tumors, Advanced Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-05-08